Form EFFECT Cellectar Biosciences,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | June 1, 2026 4:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cellectar reports 79% response rate in Waldenstrom cancer study
- Bacillus clausii 088AE Becomes the First VHP-Listed B. clausii for Dogs
- TWSE and Industry Partners Highlight Taiwan's Central Role in the Global AI and Semiconductor Race at COMPUTEX 2026
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
